Search This Blog

Wednesday, August 7, 2019

AMAG Pharmaceuticals EPS of -$3.57

AMAG Pharmaceuticals (NASDAQ:AMAG): Q2 EPS of -$3.57 may not be comparable to consensus of -$0.88.
Revenue of $78.11M (-46.6% Y/Y) misses by $12.61M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)